Corporate Support
Sitemap
Singapore

ShareInvestor.com

Mobile Edition
Mode - Streaming
Switch to Static Mode?

Price Highlight

Index Highlight

Chart
STI
3,004.9
4.9 (0.16%)

 

  • STI Straits Times Index
    3,004.9
    4.9 (0.16%)
     
  • KLCI FTSE Bursa Malaysia KLCI
    1,627.0
    -8.7 (-0.53%)
    Index delayed 15 minutes
  • HSI Hang Seng Index
    28,573.9
    77.0 (0.27%)
    Index delayed 15 minutes
  • SSE SSE Composite Index
    3,566.4
    0.5 (0.01%)
    Index delayed 15 minutes
  • N225 Nikkei 225
    28,519.2
    -179.1 (-0.62%)
    Index delayed 20 minutes
  • JCI Jakarta Composite Index
    6,373.4
    -54.9 (-0.85%)
    Index delayed 10 minutes

SGX Market

Bursa Market

HKEx Market

SET Market

IDX Market

ASX Market

NYSE Market

NASDAQ Market

NYSE American Market

  • Volume: 3,982.9M
  • Value: 1,509.5M
  • Rise: 218
  • Fall: 137
  • Unch: 425

Intraday Market Ticker Help

Intraday Market Ticker
Time Name Type Price Vol
  • Top Active

  • Top Gainer

  • Top Loser

Top Counters
Name Last Change
Incredible R0.001-
Jiutian Chemical0.100+0.002
Oceanus^0.038+0.002
DISA0.002-
AusGroup0.032-
The Place Hldg0.051+0.003
Sembcorp Marine0.169-
CWX Global0.003-0.001
Advanced Systems0.001-
MarcoPolo Marine0.017+0.001

World Indices

World Indices
Name Last Change
Nasdaq 12,998.5 -114.1
HSI 28,573.9 +77.0
HSCEI 11,320.5 +21.4
Jakarta 6,373.4 -54.9
Nikkei 225 28,519.2 -179.1
SSE Comp 3,566.4 +0.5
Shanghai A 3,738.3 +0.5
Shanghai B 250.7 +0.2
KOSPI 3,085.9 -64.0

Asian Indices delayed. US Indices updated twice daily at 7:30am and 7:30pm.

Fundamental - Factsheet

Help
  • Factsheet

  • Print

BIOHLDG BIOALPHA HOLDINGS BERHAD
Quotes 15 Minutes Delayed. Updated at 15 Jan 2021 16:58
Last (MYR): 0.270 Change: - High: 0.275 Remarks:
Change (%): - Low: 0.265
Open 0.270 Yesterday's Close 0.270
Buy Price 0.270 Sell Price 0.275
Buy Volume ('00) 514 Sell Volume ('00) 18,041
Cumulative Volume ('00) 127,223 Cumulative Value 3,437,056
Click to show Stock Prices chart

Key Statistics

EPS (MYR) a 0.00749 Trailing EPS (MYR) e -0.01811 NAV (MYR) b 0.1600
PE a 36.048 Trailing PE f - Price / NAV b 1.6875
Dividend (MYR) d - Cash In Hand (MYR) g 0.0191 Issued & Paid-up Shares c 1,110,471,000
Dividend Yield (%) d - Price / Cash In Hand g 14.136 Treasury Shares h -
Beta - 75 Daysi 1.396 R-Squared - 75 Days(%)i 12.50 Market Cap (M) 299.827
Beta - 500 Daysi 1.592 R-Squared - 500 Days (%)i 8.58 Enterprise Value (M) 285.888
Piotroski F Score 4 Exchange Code 0179 Par Value ( $ ) 0.05000
52 Weeks Volatility (%) 113.62 6-Month VWAP 0.302 Free Float (%) 64.8
Shariah Compliant Stocks Yes
Sector & Industry Health Technology - Pharmaceuticals: Major
Index Components Bursa Malaysia Consumer Products Index
Notes:
  1. Based on latest Full Year results announcement, adjusted for the current number of shares.
  2. Based on latest results announcement (Full Year, Half Year or Interim), adjusted for carrying value of "Other Share Capital", illustrative financial effects of corporate actions (if applicable) and the current number of shares.
  3. Rounded to the nearest thousand. Updated on 14 Dec 2020.Please click here for more information.
  4. Dividend is based on latest Full Year results announcement, adjusted for current number of shares and excludes special dividend.
  5. Summation of the earnings from the latest 4 Quarter (or 2 Half Year) results announcement, adjusted for the current number of shares.
  6. Based on Trailing EPS.
  7. Based on reported cash and cash equivalents at end and extracted from the latest results announcement (Full Year, Half Year or Interim), adjusted for the current number of shares.
  8. Rounded to the nearest thousand. Updated on 14 Dec 2020.
  9. Beta and R-Squared are calculated in relation to the market index using the historical daily closing values of the stock and index as data points.

Peer Comparison

Type Name Market Market Cap (M)a PE b Trailing PE c Price / NAV d Dividend Yield (%)d
Reference BIOHLDG Bursa 299.827 36.048 - 1.6875 -
Industry FOOD& BEVERAGES Bursa 2,018.039 31.937 35.381 2.8191 2.366
Pharmaceuticals: Major Bursa 877.718 10.752 10.781 0.7803 0.759
Index Bursa Malaysia Consumer Products Index Bursa 1,393.981 28.712 408.115 1.5022 2.660
Local Peer IGBB Bursa 2,291.939 10.984 28.796 0.6626 0.297
Local Peer PHARMA Bursa 1,373.957 - - 3.9761 1.616
Local Peer BSTEAD Bursa 1,347.947 - - 0.3814 -
Local Peer KOTRA Bursa 429.009 14.515 15.948 2.2136 3.052
Local Peer NOVA Bursa 295.502 22.722 21.312 3.2632 1.538
Local Peer SUNZEN Bursa 105.848 - - 1.2210 -
Global Peer JOHNSON & JOHNSON NYSE 421,996.162 27.912 24.844 6.5453 2.339
Global Peer NOVARTIS AG ADR-EACH REPR 1 CHF0.5(REGD) NYSE 235,924.948 33.473 33.015 4.3301 1.927
Global Peer MERCK & CO INC NYSE 210,953.901 21.432 18.314 7.2279 2.720
Global Peer PFIZER INC NYSE 203,993.280 12.536 23.491 3.1259 3.961
Global Peer ABBVIE INC NYSE 195,119.744 24.881 26.659 12.7779 3.327
Global Peer ELI LILLY AND COMPANY NYSE 182,487.148 39.347 32.747 37.8062 1.354
Global Peer BRISTOL-MYERS SQUIBB CO NYSE 150,363.765 43.723 - 2.9978 2.489
Global Peer ASTRAZENECA SPON ADR EACH REP 0.50 ORD SHS NASDAQ 134,784.956 100.546 53.588 11.0525 2.667
Global Peer NOVO NORDISK A/S ADR-EACH CNV INTO 1 CLASS B DKK1 NYSE 130,558.697 22.359 20.951 13.9116 1.579
Global Peer SANOFI SPON ADR ECH REP 0.5 ORD SHS NASDAQ 124,361.057 38.222 10.125 1.7491 2.366
Other Global Peers GLAXOSMITHKLINE ADR EACH CNV INTO 2 ORD GBP0.25 (NYSE), WUXI APPTEC (HKEx), TAKEDA PHARMACEUTICAL CO LTD SPON ADS EACH REP 0.5 ORD SHS (NYSE), HANSOH PHARMA (HKEx), ROYALTY PHARMA PLC (NASDAQ), VIATRIS INC (NASDAQ), CUREVAC NV (NASDAQ), INNOVENT BIO (HKEx), REPLIGEN CORP (NASDAQ), CANSINOBIO-B (HKEx), ASCENDIS PHARMA A/S SPON ADR EACH REP 1 ORD SHS (NASDAQ), SINOPHARM (HKEx), JUNSHI BIO (HKEx), ALLAKOS INC (NASDAQ), REMEGEN-B (HKEx), TURNING POINT THERAPEUTICS INC (NASDAQ), AKESO-B (HKEx), BIOHAVEN PHARMACEUTICAL HLDG CO LTD (NYSE), GRIFOLS SA SPON ADR EA REPR 1 ORD EUR0.10 (NASDAQ), SH PHARMA (HKEx), HUTCHISON CHINA MEDITECH SPON ADS EACH REPR 5 ORD SHS (NASDAQ), ATEA PHARMACEUTICALS INC (NASDAQ), HYGEIA HEALTH (HKEx), BAIYUNSHAN PH (HKEx), REATA PHARMACEUTICALS INC (NASDAQ), LEGEND BIOTECH CORP SPON ADS EACH REP 2 ORD SHS (NASDAQ), APELLIS PHARMACEUTICALS INC (NASDAQ), SPRINGWORKS THERAPEUTICS INC (NASDAQ), I MAB SPON ADS EACH REP 2.3 ORD SHS (NASDAQ), EVEREST MED-B (HKEx), CHINARES PHARMA (HKEx), IGM BIOSCIENCES INC (NASDAQ), OPKO HEALTH INC (NASDAQ), NEKTAR THERAPEUTICS (NASDAQ), SIMCERE PHARMA (HKEx), CMS (HKEx), HENLIUS-B (HKEx), CHINAGRANDPHARM (HKEx), KARUNA THERAPEUTICS INC (NASDAQ), ZYMEWORKS INC (NYSE), TRAD CHI MED (HKEx), ADC THERAPEUTICS SA (NYSE), Kimia Farma Tbk. (IDX), QUANTERIX CORPORATION (NASDAQ), OCUMENSION-B (HKEx), HARMONY BIOSCIENCES HLDGS INC (NASDAQ), HEPALINK (HKEx), PRAXIS PRECISION MEDICINES INC (NASDAQ), INNOCARE-B (HKEx), Y-MABS THERAPEUTICS INC (NASDAQ), KRONOS BIO INC (NASDAQ), GENERATION BIO CO (NASDAQ), NURIX THERAPEUTICS INC (NASDAQ), SSY GROUP (HKEx), SILVERBACK THERAPEUTICS INC (NASDAQ), ANTENGENE-B (HKEx), KINNATE BIOPHARMA INC (NASDAQ), FORMA THERAPEUTICS HLDGS INC (NASDAQ), OLEMA PHARMACEUTICALS INC (NASDAQ), ARCTURUS THERAPEUTICS HOLDINGS INC (NASDAQ), CONSTELLATION PHARMACEUTICALS INC (NASDAQ), OCULAR THERAPEUTIX INC (NASDAQ), REPARE THERAPEUTICS INC (NASDAQ), ZEALAND PHARMA AS SPON ADR EACH REP 1 ORD SHS (NASDAQ), CSTONE PHARMA-B (HKEx), CULLINAN MANAGEMENT INC (NASDAQ), AMNEAL PHARMACEUTICALS INC (NYSE), KEROS THERAPEUTICS INC (NASDAQ), KINIKSA PHARMACEUTICALS LTD (NASDAQ), KRYSTAL BIOTECH INC (NASDAQ), ORIC PHARMACEUTICALS INC (NASDAQ), UNITED LAB (HKEx), ARCUTIS BIOTHERAPEUTICS INC (NASDAQ), SUTRO BIOPHARMA INC (NASDAQ), ALIGOS THERAPEUTICS INC (NASDAQ), PHATHOM PHARMACEUTICALS INC (NASDAQ), CKLIFE SCIENCES (HKEx), TCR2 THERAPEUTICS INC (NASDAQ), PETIQ INC (NASDAQ), ANNEXON INC (NASDAQ), ATHENEX INC (NASDAQ), AKERO THERAPEUTICS INC (NASDAQ), PROVENTION BIO INC (NASDAQ), TONGRENTANGCM (HKEx), TARSUS PHARMACEUTICALS INC (NASDAQ), PHIBRO ANIMAL HEALTH CORP (NASDAQ), G1 THERAPEUTICS IN (NASDAQ), IMMUNOTECH-B (HKEx), GOSSAMER BIO INC (NASDAQ), ODONATE THERAPEUTICS INC (NASDAQ), CALLIDITAS THERAPEUTICS AB SPON ADS EACH REP 2 ORD SHS (NASDAQ), HUA MEDICINE-B (HKEx), Soho Global Health Tbk. (IDX), ORCHARD THERAPEUTICS PLC SPON ADS EACH REPR 1 ORD SHS (NASDAQ), GRAYBUG VISION INC (NASDAQ), EVELO BIOSCIENCES INC (NASDAQ), INOZYME PHARMA INC (NASDAQ), CHINOOK THERAPEUTICS INC (NASDAQ), NANOBIOTIX S A SPON ADS EACH REP 1 ORD SHS (NASDAQ), VERU INC (NASDAQ), RELMADA THERAPEUTICS INC (NASDAQ), SIGA TECHNOLOGIES INC (NASDAQ), GAMIDA CELL LTD (NASDAQ), MIRUM PHARMACEUTICALS INC (NASDAQ), ESSA PHARMA INC (NASDAQ), CODIAK BIOSCIENCES INC (NASDAQ), UROVANT SCIENCES LTD (NASDAQ), FUSION PHARMACEUTICALS INC (NASDAQ), SHINEWAY PHARM (HKEx), BEYONDSPRING INC (NASDAQ), APPLIED THERAPEUTICS INC (NASDAQ), IDEAYA BIOSCIENCES INC (NASDAQ), AMRYT PHARMA PLC (NEW) SPON ADS EACH REP 5 ORD SHS (NASDAQ), KALEIDO BIOSCIENCES INC (NASDAQ), STARPHARMA HOLDINGS LIMITED (ASX), CRINETICS PHARMACEUTICALS INC (NASDAQ), OYSTER POINT PHARMA INC (NASDAQ), SPERO THERAPEUTICS INC (NASDAQ), ORPHAZYME A/S SPON ADS REP 1 ORD SHS (NASDAQ), AC IMMUNE SA (NASDAQ), 89BIO INC (NASDAQ), FUSEN PHARM (HKEx), KALA PHARMACEUTICALS INC (NASDAQ), DURECT CORP (NASDAQ), CLENE INC (NASDAQ), AFT PHARMACEUTICALS LTD (ASX), TFF PHARMACEUTICALS INC (NASDAQ), PYC THERAPEUTICS LIMITED (ASX), IMMUNIC INC (NASDAQ), NAVIDEA BIOPHARMACEUTICALS INC (NYSE American), TRICIDA INC (NASDAQ), TOT BIOPHARM-B (HKEx), HOOKIPA PHARMA INC (NASDAQ), GALECTO INC (NASDAQ), KALVISTA PHARMACEUTICALS INC (NASDAQ), QILIAN INTERNATIONAL HLDG GROUP LTD (NASDAQ), GRITSTONE ONCOLOGY INC (NASDAQ), REDHILL BIOPHARMA LTD SPON ADS EA REPR 10 ORD ILS0.00 (NASDAQ), FULCRUM THERAPEUTICS INC (NASDAQ), MUSTANG BIO INC (NASDAQ), VINCERX PHARMA INC (NASDAQ), VERRICA PHARMACEUTICALS INC (NASDAQ), VYNE THERAPEUTICS INC (NASDAQ), LANNETT CO INC (NYSE), OSMOTICA PHARMACEUTICALS PLC (NASDAQ), TYME TECHNOLOGIES INC (NASDAQ), LOGICBIO THERAPEUTICS INC (NASDAQ), XERIS PHARMACEUTICALS INC (NASDAQ), ONCTERNAL THERAPEUTICS INC (NASDAQ), GALERA THERAPEUTICS INC (NASDAQ), DAWNRAYS PHARMA (HKEx), SOL GEL TECHNOLOGIES LTD (NASDAQ), IMARA INC (NASDAQ), CHECKPOINT THERAPEUTICS INC (NASDAQ), OBSEVA SA (NASDAQ), ETON PHARMACEUTICALS INC (NASDAQ), PROTARA THERAPEUTICS INC (NASDAQ), CLEARSIDE BIOMEDICAL INC (NASDAQ), ELEDON PHARMACEUTICALS INC (NASDAQ), MILESTONE PHARMACEUTICALS INC (NASDAQ), HARROW HEALTH INC (NASDAQ), EVOLUS INC (NASDAQ), THERATECHNOLOGIES INC (NASDAQ), PROPHASE LABS INC (NASDAQ), POLYPID LTD (NASDAQ), NOVAN INC (NASDAQ), AQUESTIVE THERAPEUTICS INC (NASDAQ), ZHONGZHIPHARM (HKEx), RACE ONCOLOGY LTD (ASX), NEUBASE THERAPEUTICS INC (NASDAQ), SCPHARMACEUTICALS INC (NASDAQ), AYALA PHARMACEUTICALS INC (NASDAQ), CH BIOTECH SER (HKEx), EYENOVIA INC (NASDAQ), CRESO PHARMA LTD (ASX), GENPREX INC (NASDAQ), EYEPOINT PHARMACEUTICALS INC (NASDAQ), OVID THERAPEUTICS INC (NASDAQ), BIOMX INC (NYSE American), AILERON THERAPEUTICS INC (NASDAQ), RECCE PHARMACEUTICALS LTD (ASX), LYRA THERAPEUTICS INC (NASDAQ), MEDIWOUND LTD (NASDAQ), Phapros Tbk. (IDX), IX Biopharma (SGX), LIQUIDIA CORPORATION (NASDAQ), PHASEBIO PHARMACEUTICALS INC (NASDAQ), IP (SET), CORVUS PHARMACEUTICALS INC (NASDAQ), NC HEALTHCARE (HKEx), APTORUM GROUP LIMITED (NASDAQ), Merck Tbk. (IDX), NOXOPHARM LTD (ASX), CYCLERION THERAPEUTICS INC (NASDAQ), APREA THERAPEUTICS INC (NASDAQ), AKARI THERAPEUTICS PLC SPON ADR EACH REPR 100 ORD (NASDAQ), AVENUE THERAPEUTICS INC (NASDAQ), SATSUMA PHARMACEUTICALS INC (NASDAQ), NEW RAY MEDIC (HKEx), LANTERN PHARMA INC (NASDAQ), REVIVA PHARMACEUTICALS HOLDINGS INC (NASDAQ), ONCOSIL MEDICAL LIMITED (ASX), F-STAR THERAPEUTICS INC (NASDAQ), Hyphens Pharma (SGX), OCUPHIRE PHARMA INC (NASDAQ), PURPLE BIOTECH LTD SPON ADS EACH REP 10 ORD SHS (NASDAQ), PAK FAH YEOW (HKEx), ALLENA PHARMACEUTICALS INC (NASDAQ), ADAMIS PHARMACEUTICALS CORPORATION (NASDAQ), CHARMACY PHAR (HKEx), ARIDIS PHARMACEUTICAL INC (NASDAQ), NEP INTERLONG (HKEx), PALLA PHARMA LTD (ASX), AGEX THERAPEUTICS INC (NYSE American), ANNOVIS BIO INC (NYSE American), INHIBIKASE THERAPEUTICS INC (NASDAQ), EXOPHARM LTD (ASX), VIRIOS THERAPEUTICS INC (NASDAQ), ASSERTIO HOLDINGS INC (NASDAQ), CITIUS PHARMACEUTICALS INC (NASDAQ), MOLECULIN BIOTECH INC (NASDAQ), DARE BIOSCIENCE INC (NASDAQ), BRICKELL BIOTECH INC (NASDAQ), ADDEX THERAPEUTICS LIMITED SPON ADS EACH REP 6 ORD SHS (NASDAQ), PDS BIOTECHNOLOGY CORPORATION (NASDAQ), WAI YUEN TONG (HKEx), MEDLAB CLINICAL LIMITED (ASX), AERPIO PHARMACEUTICALS INC (NASDAQ), YUMANITY THERAPEUTICS INC (NASDAQ), 180 LIFE SCIENCES CORP (NASDAQ), TREVI THERAPEUTICS INC (NASDAQ), EDESA BIOTECH INC (NASDAQ), ACER THERAPEUTICS INC (NASDAQ), CNS PHARMACEUTICALS INC (NASDAQ), TBG DIAGNOSTICS LTD (ASX), BIONDVAX PHARMACEUTICALS SPON ADS REP 40 ORD SHS (NASDAQ), INVION LTD (ASX), PETROS PHARMACEUTICALS INC (NASDAQ), IMMURON LIMITED (ASX), IMMURON LIMITED SPON ADR EACH REPR 40 ORD SHS (NASDAQ), EXTRAWELL PHAR (HKEx), PANBELA THERAPEUTICS INC (NASDAQ), PAINREFORM LTD (NASDAQ), BAUDAX BIO INC (NASDAQ), MANNATECH INC (NASDAQ), JCT (SET), CHINA SXT PHARMACEUTICALS INC (NASDAQ), SANAI HEALTH GP (HKEx), PURAPHARM (HKEx), ACRUX (ASX), MILLENDO THERAPEUTICS INC (NASDAQ), TALI DIGITAL LIMITED (ASX), PHARMAXIS (ASX), HOTH THERAPEUTICS INC (NASDAQ), ADIAL PHARMACEUTICALS INC (NASDAQ), ENTERA BIO LTD (NASDAQ), TITAN PHARMACEUTICAL INC (NASDAQ), TELIGENT INC NEW (NASDAQ), SINOLIFE UTD (HKEx), FIJI KAVA LTD (ASX), SUDA PHARMACEUTICALS LTD (ASX), TIMBER PHARMACEUTICALS INC (NYSE American), CELLMID LIMITED (ASX), FARMAFORCE LTD (ASX), PASHUN INT'L (HKEx), Pharmesis Intl (SGX)
Notes:
  1. For companies, Market Cap is based on the trading currency of the company. Industry/Index Market Cap is the average market cap for that industry/index.
  2. Industry/Index PE is calculated using (Total Market Cap/Total Earnings) of all companies in the industry/index.
  3. Industry/Index Price/NAV is calculated using (Total Market Cap/Total Shareholders' Equity) of all companies in the industry/index.
  4. Industry/Index Dividend Yield is calculated using (Total Gross Dividend/Total Market Cap) of all companies in the industry/index.
  5. For Industry/Index calculation, data for foreign currency denominated companies will be converted to the main market currency using the latest exchange rate.
  6. Industry/Index/Peers data is updated daily.
  7. Peers are sorted by market capitalisation and only details for the top 10 will be shown.

Total Shareholder Return

PeriodDividend ReceivedCapital AppreciationTotal Shareholder Return
Short Term Return 5 Days -+0.010
+3.85 %
10 Days --0.010
-3.57 %
20 Days --0.030
-10.00 %
Medium Term Return 3 Months -+0.010
+3.85 %
6 Months -+0.145
+116.00 %
1 Year -+0.080
+42.11 %
Long Term Return 2 Years -+0.065
+31.71 %
3 Years 0.001+0.025
+10.61 %
5 Years 0.002+0.033
+14.77 %
Annualised Return Annualised --
+2.79 %
Notes:
  1. Total Shareholder Return (TSR) combines share price appreciation and dividends paid to show the total return to the shareholder expressed as a percentage.
  2. Script dividends are ignored in this calculation.

Price Movements

1 Year Range 0.065 - 0.395 Change From 1 Year Low +0.205 % Change From 1 Year Low (%) +315.38
Change From 1 Year High -0.125 % Change From 1 Year High (%) -31.65
2 Years Range 0.065 - 0.395 Change From 2 Years Low +0.205 % Change From 2 Years Low (%) +315.38
Change From 2 Years High -0.125 % Change From 2 Years High (%) -31.65
5 Years Range 0.065 - 0.395 Change From 5 Years Low +0.205 % Change From 5 Years Low (%) +315.38
Change From 5 Years High -0.125 % Change From 5 Years High (%) -31.65
Notes:
  1. Price movements are based on adjusted historical data.

Company Background

IPO Performance

Listing Date 14 Apr 2015 Full Subscription Rate (x) -
No of Placement Shares (M) - No of Public Offer Shares (M) 20.00 Public Offer Subscription Rate (x) -
IPO Price (MYR) 0.200 First Day Close (MYR) 0.270 First Week Close (MYR) 0.415
Current vs IPO Price (%) +35.00 First Day Gain (%) +35.00 First Week Gain (%) +107.50

Reports Download

Report Type Financial Year Ended Download
Annual Report
Annual Report 2018 Dec 2018 Part 1(2.25 MB)
Part 2(1.98 MB)
Annual Report 2017 Dec 2017 Part 1(2.33 MB)
Part 2(0.51 MB)
Annual Report 2016 Dec 2016 Part 1(2.31 MB)
Part 2(2.89 MB)
Annual Report 2015 Dec 2015 Part 1(1.87 MB)
Part 2(2.71 MB)
Annual Report 2014 Dec 2014 Part 1(2.18 MB)
Part 2(2.21 MB)
Part 3(0.08 MB)

Historical Price Data

Date Open High Low Close Volume VWAP
15 Jan 2021 0.270 0.275 0.265 0.270 12,722,300 0.2702
14 Jan 2021 0.275 0.275 0.265 0.270 6,968,100 0.2699
13 Jan 2021 0.275 0.280 0.270 0.270 9,550,800 0.2735
12 Jan 2021 0.265 0.280 0.260 0.270 14,030,800 0.2685
11 Jan 2021 0.265 0.275 0.265 0.265 8,816,700 0.2689
08 Jan 2021 0.275 0.280 0.255 0.260 26,763,600 0.2665
07 Jan 2021 0.280 0.290 0.275 0.275 26,627,100 0.2791
06 Jan 2021 0.285 0.290 0.275 0.280 14,247,100 0.2817
05 Jan 2021 0.280 0.290 0.280 0.285 20,744,500 0.2846
04 Jan 2021 0.285 0.285 0.275 0.280 18,541,900 0.2813
31 Dec 2020 0.290 0.290 0.280 0.280 12,790,900 0.2846
30 Dec 2020 0.285 0.290 0.285 0.290 9,410,800 0.2865
29 Dec 2020 0.290 0.295 0.285 0.285 12,208,500 0.2874
28 Dec 2020 0.285 0.300 0.285 0.290 24,641,600 0.2918
24 Dec 2020 0.290 0.295 0.285 0.285 9,154,200 0.2864
23 Dec 2020 0.285 0.295 0.280 0.290 17,658,600 0.2864
22 Dec 2020 0.290 0.295 0.280 0.290 36,956,200 0.2863
21 Dec 2020 0.300 0.305 0.290 0.295 14,758,800 0.2961
18 Dec 2020 0.305 0.305 0.290 0.300 18,406,800 0.2942
17 Dec 2020 0.300 0.310 0.290 0.305 26,423,600 0.3009
16 Dec 2020 0.285 0.300 0.280 0.295 38,758,000 0.2921
15 Dec 2020 0.280 0.290 0.275 0.285 22,153,800 0.2813
Summary
Current 2 Weeks
(04 Jan 2021 to 15 Jan 2021)
0.285 0.290 0.255 0.270 159,012,900 -
Previous 2 Weeks
(17 Dec 2020 to 31 Dec 2020)
0.300 0.310 0.255 0.280 182,410,000 -
4 Weeks from
(19 Nov 2020 to 16 Dec 2020)
0.285 0.295 0.255 0.295 1,679,357,000 -
View All Historical Data

More Information Available

More information is available to our subscribers, including:

  • Market Moving News from Dow Jones Newswires
  • Consensus Estimates
  • Dividend/Distribution History
  • Financial Summary with Financial Period Comparison
  • Comprehensive Financial Ratios(ROA, ROE, Price/Revenue, Net Earnings Margin, Current Ratio, Debt to Equity Ratio etc)
  • Events Calendar for Results Announcements, Ex-Dates etc
  • Insider Buying and Selling Report

If you are an existing subscriber, please login. If not, read up on what you are missing out in our Help Centre and join us as a subscriber.

Disclaimer:

While reasonable efforts have been taken to ensure that the calculations performed by the features of this site are reliable, the features are provided on the basis that:-

  1. no liability is accepted for any errors or inaccuracies resulting from your use of these features;
  2. many of the data inputs (including share prices) are obtained from third party sources for which we assume no responsibility.
We use Cookies. By continuing to use this webite, you will be agreeing to our Privacy Policy, Terms and Conditions and Cookie Policy.